BD3696648
Ethyl2-(diethoxyphosphoryl)butanoate , 98% , 17145-91-4
Synonym(s):
α-Diethylphosphonobutanoic acid ethyl ester;Ethyl 2-(diethoxyphosphoryl)butanoate;NSC 22423
| Pack Size | Price | Stock | Quantity |
| 1g | RMB68.80 | In Stock |
|
| 5g | RMB232.80 | In Stock |
|
| 25g | RMB790.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 152-154 °C14 mm Hg(lit.) |
| Density | 1.064 g/mL at 25 °C(lit.) |
| refractive index | n |
| Flash point: | >230 °F |
| storage temp. | Sealed in dry,Room Temperature |
| form | Liquid |
| Specific Gravity | 1.064 |
| color | Clear colorless |
| Water Solubility | Not miscible or difficult to mix with water. |
| BRN | 1789280 |
Description and Uses
Reactant for preparation of:
- Furospinosulin-1 and analogs as hypoxia-selective antitumor agents
- Aminoquinolines as beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and potential anti-Alzheimer′s drugs
- Phenylpropanoic acid peroxisome proliferator-activated receptor (PPAR) α-selective agonists as nonalcoholic steatohepatitis (NASH)-preventive agents
- PPAR agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related LXR antagonists
- Notch-sparing γ-secretase inhibitors derived from PPAR agonist library
- Plakotenin via Diels-Alder reaction, as a potential anticancer agent, naturally found in Okinawan sponge of the genus Plakortis
- Quinone/naphthoquinone-substituted propenoic acids as inhibitors of cell growth and redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor 1 (Ape1/Ref-1)
- α-alkenyl cyclic ethers by asymmetric dehydrative cyclization of ω-hydroxy allyl alcohols catalyzed by Ru complexes of axially chiral naphthylpyridinecarboxylates
- Branched phosphonoethoxyethyl purines as new acyclic nucleoside phosphonates which inhibit Plasmodium falciparum (malarial parasite) hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT)
- Phenylpropanoic acid-type peroxisome proliferator-activated receptor pan agonists as candidate drugs for treatment of altered metabolic homeostasis
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| WGK Germany | 3 |
| HS Code | 29310099 |
